Cargando…

The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010

BACKGROUND: Renal replacement therapy (RRT) incidence has increased significantly in Sweden during the past decades. This study analyses variations in time and regional trends in RRT incidence in Sweden, adjusted for age and gender, focusing on the impact change in incidence during the last decade....

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Abdul Rashid, Evans, Marie, Stendahl, Maria, Prütz, Karl-Göran, Elinder, Carl-Gustaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400478/
https://www.ncbi.nlm.nih.gov/pubmed/26064505
http://dx.doi.org/10.1093/ckj/sft032
_version_ 1782367032047566848
author Qureshi, Abdul Rashid
Evans, Marie
Stendahl, Maria
Prütz, Karl-Göran
Elinder, Carl-Gustaf
author_facet Qureshi, Abdul Rashid
Evans, Marie
Stendahl, Maria
Prütz, Karl-Göran
Elinder, Carl-Gustaf
author_sort Qureshi, Abdul Rashid
collection PubMed
description BACKGROUND: Renal replacement therapy (RRT) incidence has increased significantly in Sweden during the past decades. This study analyses variations in time and regional trends in RRT incidence in Sweden, adjusted for age and gender, focusing on the impact change in incidence during the last decade. METHODS: Using data from the Swedish Renal Registry (SRR) (21 counties in Sweden, total population 9 million), we identified all incident subjects starting RRT from 1991 through 2010. Only individuals alive following 90 days of RRT start were included. Gender- and age-specific standardized RRT incidences on an annual and regional basis were calculated, and differences between counties and variations over time were examined. We compared the overall age and gender-adjusted RRT incidence rates for Sweden by calendar year. Furthermore, we also calculated the age and gender-adjusted RRT incidence in each county during two time periods (1991–1999 versus 2000–2010). RESULTS: There were 20 172 new subjects treated with RRT between January 1991 and December 2010. The most common cause of end-stage renal disease (ESRD) was diabetes (24%) and hypertension/renal vascular disease (19%), followed by glomerulonephritis (16%). Sixty-four percent of new patients were male; the median age when commencing RRT was 66 years (10–90 percentiles; 39–80). The overall standardized RRT incidence reached its peak in 2000, and slowly decreased thereafter. A decrease in RRT incidence was observed over the study period in eight regions. The standardized RRT incidence varied between the different counties, from 0.82 to 1.19. CONCLUSIONS: Adjusted for demographic changes in the population, an overall decrease in RRT incidence was observed from the year 2000 onwards—suggesting that the previously reported steady increase in RRT incidence is coming to an end in Sweden. Noteworthy differences were found between counties and in 8 out of 21 counties, a decreased incidence of RRT was found. Further studies need to identify the factors that contribute to this decrease.
format Online
Article
Text
id pubmed-4400478
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44004782015-06-10 The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010 Qureshi, Abdul Rashid Evans, Marie Stendahl, Maria Prütz, Karl-Göran Elinder, Carl-Gustaf Clin Kidney J Educational Papers BACKGROUND: Renal replacement therapy (RRT) incidence has increased significantly in Sweden during the past decades. This study analyses variations in time and regional trends in RRT incidence in Sweden, adjusted for age and gender, focusing on the impact change in incidence during the last decade. METHODS: Using data from the Swedish Renal Registry (SRR) (21 counties in Sweden, total population 9 million), we identified all incident subjects starting RRT from 1991 through 2010. Only individuals alive following 90 days of RRT start were included. Gender- and age-specific standardized RRT incidences on an annual and regional basis were calculated, and differences between counties and variations over time were examined. We compared the overall age and gender-adjusted RRT incidence rates for Sweden by calendar year. Furthermore, we also calculated the age and gender-adjusted RRT incidence in each county during two time periods (1991–1999 versus 2000–2010). RESULTS: There were 20 172 new subjects treated with RRT between January 1991 and December 2010. The most common cause of end-stage renal disease (ESRD) was diabetes (24%) and hypertension/renal vascular disease (19%), followed by glomerulonephritis (16%). Sixty-four percent of new patients were male; the median age when commencing RRT was 66 years (10–90 percentiles; 39–80). The overall standardized RRT incidence reached its peak in 2000, and slowly decreased thereafter. A decrease in RRT incidence was observed over the study period in eight regions. The standardized RRT incidence varied between the different counties, from 0.82 to 1.19. CONCLUSIONS: Adjusted for demographic changes in the population, an overall decrease in RRT incidence was observed from the year 2000 onwards—suggesting that the previously reported steady increase in RRT incidence is coming to an end in Sweden. Noteworthy differences were found between counties and in 8 out of 21 counties, a decreased incidence of RRT was found. Further studies need to identify the factors that contribute to this decrease. Oxford University Press 2013-06 /pmc/articles/PMC4400478/ /pubmed/26064505 http://dx.doi.org/10.1093/ckj/sft032 Text en © The Author 2013. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please email: journals.permissions@oup.com http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Educational Papers
Qureshi, Abdul Rashid
Evans, Marie
Stendahl, Maria
Prütz, Karl-Göran
Elinder, Carl-Gustaf
The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010
title The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010
title_full The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010
title_fullStr The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010
title_full_unstemmed The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010
title_short The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010
title_sort increase in renal replacement therapy (rrt) incidence has come to an end in sweden—analysis of variations by region over the period 1991–2010
topic Educational Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400478/
https://www.ncbi.nlm.nih.gov/pubmed/26064505
http://dx.doi.org/10.1093/ckj/sft032
work_keys_str_mv AT qureshiabdulrashid theincreaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT evansmarie theincreaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT stendahlmaria theincreaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT prutzkarlgoran theincreaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT elindercarlgustaf theincreaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT qureshiabdulrashid increaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT evansmarie increaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT stendahlmaria increaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT prutzkarlgoran increaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010
AT elindercarlgustaf increaseinrenalreplacementtherapyrrtincidencehascometoanendinswedenanalysisofvariationsbyregionovertheperiod19912010